Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

Archive ouverte

Saunders, Nell | Planas, Delphine | Bolland, William | Rodriguez, Christophe | Fourati, Slim | Buchrieser, Julian | Planchais, Cyril | Prot, Matthieu | Staropoli, Isabelle | Guivel-Benhassine, Florence | Porrot, Françoise | Veyer, David | Péré, Hélène | Robillard, Nicolas | Saliba, Madelina | Baidaliuk, Artem | Seve, Aymeric | Hocqueloux, Laurent | Prazuck, Thierry | Rey, Felix | Mouquet, Hugo | Simon-Lorière, Etienne | Bruel, Timothée | Pawlotsky, Jean-Michel | Schwartz, Olivier

Edité par CCSD ; Elsevier -

International audience. Background: SARS-CoV-2 lineages are continuously evolving. As of December 2021, the AY.4.2 Delta sub-lineage represented 20 % of sequenced strains in the UK and had been detected in dozens of countries. It has since then been supplanted by Omicron. The AY.4.2 spike displays three additional mutations (T95I, Y145H and A222V) in the N-terminal domain when compared to the original Delta variant (B.1.617.2) and remains poorly characterized.Methods: We compared the Delta and the AY.4.2 spikes, by assessing their binding to antibodies and ACE2 and their fusogenicity. We studied the sensitivity of an authentic AY.4.2 viral isolate to neutralizing antibodies.Findings: The AY.4.2 spike exhibited similar binding to all the antibodies and sera tested, and similar fusogenicity and binding to ACE2 than the ancestral Delta spike. The AY.4.2 virus was slightly less sensitive than Delta to neutralization by a panel of monoclonal antibodies; noticeably, the anti-RBD Imdevimab showed incomplete neutralization. Sensitivity of AY.4.2 to sera from vaccinated individuals was reduced by 1.3 to 3-fold, when compared to Delta.Interpretation: Our results suggest that mutations in the NTD remotely impair the efficacy of anti-RBD antibodies. The spread of AY.4.2 was not due to major changes in spike fusogenicity or ACE2 binding, but more likely to a partially reduced neutralization sensitivity.

Suggestions

Du même auteur

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Archive ouverte | Planas, Delphine | CCSD

International audience. The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1,2,3,4,5. Since then, it has become dominant in some regions of India and in the UK, and has spread to many other countr...

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

Archive ouverte | Bolland, William | CCSD

International audience. ABSTRACT SARS-CoV-2 variants with undetermined properties have emerged intermittently throughout the COVID-19 pandemic. Some variants possess unique phenotypes and mutations which allow furth...

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies

Archive ouverte | Schwartz, Olivier | CCSD

International audience. The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 mutations in its s...

Chargement des enrichissements...